JP2011093891A5 - - Google Patents

Download PDF

Info

Publication number
JP2011093891A5
JP2011093891A5 JP2010219798A JP2010219798A JP2011093891A5 JP 2011093891 A5 JP2011093891 A5 JP 2011093891A5 JP 2010219798 A JP2010219798 A JP 2010219798A JP 2010219798 A JP2010219798 A JP 2010219798A JP 2011093891 A5 JP2011093891 A5 JP 2011093891A5
Authority
JP
Japan
Prior art keywords
composition
carboxyvinyl polymer
ophthalmic
ruberin
tetrahydrozoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010219798A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011093891A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2010219798A priority Critical patent/JP2011093891A/ja
Priority claimed from JP2010219798A external-priority patent/JP2011093891A/ja
Publication of JP2011093891A publication Critical patent/JP2011093891A/ja
Publication of JP2011093891A5 publication Critical patent/JP2011093891A5/ja
Pending legal-status Critical Current

Links

JP2010219798A 2009-09-30 2010-09-29 眼科用組成物 Pending JP2011093891A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010219798A JP2011093891A (ja) 2009-09-30 2010-09-29 眼科用組成物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2009228119 2009-09-30
JP2010219798A JP2011093891A (ja) 2009-09-30 2010-09-29 眼科用組成物

Publications (2)

Publication Number Publication Date
JP2011093891A JP2011093891A (ja) 2011-05-12
JP2011093891A5 true JP2011093891A5 (es) 2014-05-08

Family

ID=44111225

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010219798A Pending JP2011093891A (ja) 2009-09-30 2010-09-29 眼科用組成物

Country Status (1)

Country Link
JP (1) JP2011093891A (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6687781B1 (ja) * 2019-03-08 2020-04-28 ロート製薬株式会社 刺激感が抑制された眼科組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6159458A (en) * 1997-11-04 2000-12-12 Insite Vision Sustained release ophthalmic compositions containing water soluble medicaments
JP2003055201A (ja) * 2001-08-13 2003-02-26 Lion Corp ビタミンａ類含有可溶化組成物及びビタミンａ類の安定化方法
JP2003201241A (ja) * 2001-10-22 2003-07-18 Rohto Pharmaceut Co Ltd 眼科用組成物
JP2004123634A (ja) * 2002-10-03 2004-04-22 Lion Corp 眼科用組成物
JP2006104114A (ja) * 2004-10-04 2006-04-20 Rohto Pharmaceut Co Ltd 粘膜適用組成物
JP4890829B2 (ja) * 2005-09-30 2012-03-07 ロート製薬株式会社 アズレン含有水性液剤
JP2008209677A (ja) * 2007-02-27 2008-09-11 Menicon Co Ltd 殺菌剤不活化液剤
JP5235358B2 (ja) * 2007-08-24 2013-07-10 ロート製薬株式会社 レボカバスチンとリドカインを含有する水性医薬組成物

Similar Documents

Publication Publication Date Title
AR079890A1 (es) Estabilizacion de peliculas de oxido de zinc en composiciones bucales
ES2556585T3 (es) Composiciones que comprenden sulfato de salbutamol
CO6640311A2 (es) Compuestos, composiciones de tioacetato y métodos de uso
EA201070477A1 (ru) Транс-кломифен для лечения метаболического синдрома
MX342423B (es) Metodos para usar inhibidores de cotransportadores 1 y 2 de glucosa y sodio.
RS53056B (en) PHARMACEUTICAL PREPARATION CONTAINING (1S) -1,5-ANHYDRO-1- [5- (4-ETHOXYBENZYL) -2-METHOXY-4-METHYLPHENYL] -1-THI-D-GLUCITOL AND METFORMIN AND ITS USE IN THE TREATMENT OF DIABETES
JP2013522425A5 (es)
BR112014009087A2 (pt) formulações de etanercept estabilizadas com xilitol
JP2016510019A5 (es)
CL2014001437A1 (es) Compuestos derivados de aril dihidropiridinona y piperidinona como inhibidores de monoacilglicerol aciltransferasa (mgat2); composicion y combinacion farmaceutica; y uso en el tratamiento y prevencion de diabetes, hiperglucemia, retinopatia, sindrome metabolico, entre otras enfermedades.
UA111717C2 (uk) Склад для перорального введення і ліпофільні солі метилналтрексону
PH12014502567A1 (en) Piperidine derivatives for gpr119 agonist
JP2013541600A5 (es)
JP2014520090A5 (es)
EA201390799A1 (ru) Триазолопиридины
JP2009178558A5 (es)
BRPI0917502A2 (pt) composição farmacêtica, e, métodos para usar um ácido orgânico ou um antioxidante, para evitar a descoloração causada quando ácido tranemaxâmico e ácido ascórbico são incorporados em uma mesma composição, e para produzir uma preparação farmacêutica sólida para administração oral
EA201170512A1 (ru) Композиция для перорального введения
AR085616A1 (es) Composicion farmaceutica inhalable que comprende glicopirrolato, uso
EA201492091A1 (ru) Фармацевтические композиции для местного применения, содержащие тербинафид и мочевину
BR112015007879A2 (pt) inibidores do vírus da hepatite c
EA201201109A1 (ru) Прасугрель в тонкоизмельченной кристаллической форме и фармацевтическая композиция, содержащая его
WO2012174096A3 (en) Personal care compositions comprising a di-amido gellant and methods of using
RS53826B1 (en) A COMPOSITION CONTAINING WHOLE EGG IN POWDER FOR USE FOR THE TREATMENT OF MELITUS DIABETES
EA201391198A1 (ru) Несмываемая, нетвердая, кондиционирующая кожу композиция, которая имеет диспергирующую масляную фазу и содержит 12-гидроксистеариновую кислоту